Home/Filings/4/0001209191-11-031082
4//SEC Filing

LARSON CHRISTINE R 4

Accession 0001209191-11-031082

CIK 0000882104other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 8:20 PM ET

Size

8.9 KB

Accession

0001209191-11-031082

Insider Transaction Report

Form 4
Period: 2011-05-23
LARSON CHRISTINE R
Vice President and CFO
Transactions
  • Award

    Common Stock

    2011-05-23+18,30062,049 total
Footnotes (1)
  • [F1]The shares will vest on December 31, 2012, provided Ms. Larson is continuously employed by the Company through such date. In the event Ms. Larson is terminated by PDL without cause or resigns for good reason, the shares shall ratably accelerate and vest in proportion to the time lapsed during the vesting period. During the vesting period, Ms. Larson has the right to vote the shares and will receive any dividends and other shareholder distributions paid by PDL. Such dividends and other distributions shall accumulate with interest and will vest and pay if and when the underlying shares vest.

Issuer

PDL BIOPHARMA, INC.

CIK 0000882104

Entity typeother

Related Parties

1
  • filerCIK 0001270013

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 8:20 PM ET
Size
8.9 KB